NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-205-2018-0-EP-06 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND CD20 AND THEIR USES EP National Stage 19787115.5 Pending
NIAID E-198-2025-0-US-14 VIRAL SEROLOGY ASSAYS US 63/161,019 Expired
NCI E-040-2012-0-KR-62 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR DIV 10-2021-7007607 Pending
NCI E-080-2020-0-PCT-02 USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS PCT PCT PCT/US2021/021831 Expired
NCI E-205-2018-0-CA-04 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND
CD20 AND THEIR USES 		CA National Stage 3112584 Pending
NCATS E-026-2016-0-EA-22 Compounds for Improving MRNA Splicing EA DIV 202190500 Issued
NCI E-143-2017-0-US-06 CONFORMATIONAL RESTRICTION OF CYANINE FLUOROPHORES IN FAR-RED AND NEAR-IR RANGE US CON 17/198,004 11707537 Issued PDF
NIDCR E-107-2022-1-US-01 Methods Of Dosing Triphenyl Calcilytic Compounds US 63/159,397 Abandoned
NHLBI E-134-2017-3-US-17 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 US CON 17/195,766 11827690 Issued PDF
NCI E-075-2020-0-PCT-02 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES PCT PCT PCT/US2021/021525 Expired
NCI E-016-2019-0-US-03 Methods for Decreasing Influenza-Induced Lethality using Gastrin-Releasing Peptide (GRP) Inhibitors or Gastrin-Releasing Peptide Receptor (GRPR) Antagonists US National Stage 17/274,564 Pending
NIAID E-131-2020-8-VE-06 Anti-Coronavirus Antibodies And Methods Of Use VE ORD 2021-000050 Pending
NCI E-229-2014-0-US-10 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION US CON 17/195,072 12171818 Issued PDF
NIAID E-131-2020-8-TW-05 Anti-Coronavirus Antibodies And Methods Of Use TW ORD 110108164 Issued
NIAID E-234-2016-1-US-04 PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE US DIV 17/194,834 11964010 Issued PDF
NIAID E-081-2013-4-AU-17 Prefusion RSV F Proteins And Their Use AU DIV 2021201468 Issued
NIAID E-131-2020-8-AR-03 Anti-Coronavirus Antibodies And Methods Of Use AR ORD 20210100595 Pending
NIAID E-531-2013-2-EP-08 Epstein-Barr Virus Vaccines EP DIV 21161239.5 Pending
NIAID E-131-2020-8-PK-08 Anti-Coronavirus Antibodies And Methods Of Use PK ORD 196/2021 Pending
NIDDK E-043-2020-0-US-02 RNA TARGET ENRICHMENT OR DEPLETION OF BIOLOGICAL SAMPLES US ORD 17/193,652 12071616 Issued PDF
NIDDK E-043-2020-0-PC-01 RNA Target Enrichment or Depletion of Biological Supplies PCT PCT PCT/US2021/021147 Expired
NHLBI E-134-2017-3-BR-19 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 BR DIV BR1220210042160 Pending
NIBIB E-076-2020-0-US-02 Fluorescence Scanning System For Analytical Ultracentrifugation US ORD 17/192,623 12287265 Abandoned PDF
NLM E-125-2017-2-JP-05 CRYSTAL STRUCTURE OF CRISPR CPF1 JP DIV 2021-034456 Issued
NIAID E-131-2020-8-PCT-01 Anti-Coronavirus Antibodies And Methods Of Use PCT PCT COMB PCT/US2021/020843 Expired
NIAID E-052-2021-0-PCT-02 Engineered Influenza Neuraminidase Antigens PCT PCT PCT/US2021/020804 Expired
NIAID E-052-2021-0-US-02 Engineered Influenza Neuraminidase Antigens US National Stage 17/904,157 Pending
NIAID E-131-2020-8-US-02 Anti-Coronavirus Antibodies And Methods Of Use US ORD 17/192,243 Abandoned
NIAID E-131-2020-8-HK-01 Anti-Coronavirus Antibodies And Methods Of Use HK EP 62023075291.2 Pending
NIAID E-131-2020-8-CN-01 Anti-Coronavirus Antibodies And Methods Of Use CN National Stage 202180033718.9 Pending
NIAID E-052-2021-0-CN-01 Engineered Influenza Neuraminidase Antigens CN National Stage 202180019311.0 Pending
NIAID E-131-2020-8-EP-18 Anti-Coronavirus Antibodies And Methods Of Use EP National Stage 21719305.1 Pending
NIAID E-052-2021-0-EP-01 Engineered Influenza Neuraminidase Antigens EP National Stage 21719304.4 Pending
NIAID E-131-2020-8-JP-01 Anti-Coronavirus Antibodies And Methods Of Use JP National Stage 2022-554815 Pending
NIAID E-131-2020-8-CA-10 Anti-Coronavirus Antibodies And Methods Of Use CA National Stage 3171139 Pending
NIAID E-131-2020-8-EG-17 Anti-Coronavirus Antibodies And Methods Of Use EG National Stage 1289/2022 Pending
NIAID E-131-2020-8-BR-09 Anti-Coronavirus Antibodies And Methods Of Use BR National Stage 112022017930-8 Pending
NIAID E-131-2020-8-AU-13 Anti-Coronavirus Antibodies And Methods Of Use AU National Stage 2021234242 Abandoned
NIAID E-052-2021-0-AU-01 Engineered Influenza Neuraminidase Antigens AU National Stage 2021231832 Pending
NIAID E-131-2020-8-IL-11 Anti-Coronavirus Antibodies And Methods Of Use IL National Stage 296333 Pending
NIAID E-131-2020-8-IN-01 Anti-Coronavirus Antibodies And Methods Of Use IN National Stage 202217053136 Pending
NIAID E-052-2021-0-ZA-01 Engineered Influenza Neuraminidase Antigens ZA National Stage 2022/09477 Pending
NIAID E-052-2021-0-SG-01 Engineered Influenza Neuraminidase Antigens SG National Stage 11202252530H Pending
NIAID E-131-2020-8-RU-12 Anti-Coronavirus Antibodies And Methods Of Use RU National Stage 2022124024 Pending
NIAID E-131-2020-8-SA-01 Anti-Coronavirus Antibodies And Methods Of Use SA National Stage 522440455 Pending
NIAID E-131-2020-8-ZA-16 Anti-Coronavirus Antibodies And Methods Of Use ZA National Stage 2022/10038 Pending
NIAID E-131-2020-8-KR-14 Anti-Coronavirus Antibodies And Methods Of Use KR National Stage 10-2022-7032747 Pending
NIAID E-131-2020-8-MX-15 Anti-Coronavirus Antibodies And Methods Of Use MX National Stage MX/a/2022/011141 Pending
NCI E-230-2020-0-US-03 Recurrence Gene Signature Across Multiple Cancer Types US National Stage 17/273,014 Pending
NCI E-239-2017-0-HK-18 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS HK EP 62021026617.2 Pending